Search
forLearn
5 / 801 resultsResearch
5 / 1000+ results
research A Critical Evaluation on Akala Palitam
Premature graying of hair is linked to an imbalance of body energies in Ayurveda and treatment varies based on the specific imbalance.
research EFFICACY OF MADHUKA TAILA NASYA AND JAPAAKUSUMA LEPA IN AKAALAPALITYA-A SINGLE CASE STUDY
Ayurvedic treatments showed promise in treating premature graying of hair without harmful effects.
research An Ayurvedic Approach to Palitya (Premature Greying of Hair)
Ayurveda suggests holistic methods to address premature greying of hair.
research Concept of Hair Problems and its Treatment in Ayurveda
Ayurveda treats hair problems like hair loss and dandruff by balancing body elements and using natural remedies like Indian Gooseberry and false Daisy.
research Akala Palitya: An Ayurvedic Review
Premature graying of hair is increasing due to stress, genetics, and pollution.
Community Join
5 / 1000+ resultscommunity 2nd Year Update FINASTERIDE ONLY from the PHILIPPINEE
A 48-year-old male from the Philippines shared his two-year progress using finasteride only for hair regrowth, experiencing significant improvement without minoxidil. He started with 0.5mg and increased to 1.25mg, later adjusting to every other day due to elevated liver enzymes, and reported 90% hair restoration.
community Anyone else taking Litfulo (ritlecitinib) to treat their alopecia?
A user diagnosed with Alopecia Areata started using Litfulo (ritlecitinib), kenalog shots, and mometasone furoate 0.1%. They shaved their head and are seeking others' experiences with Litfulo.
community Olumiant alternative for Alopecia Areata?
A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.
community PP405 2a study was a safety study. Some rational explaining.
The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.
community Pp405 phase 2a clinical results
PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.